Estimates Revisions Actuate Therapeutics, Inc.

Stocks

Delayed Nasdaq 21:58:45 26/08/2026 +04			5-day change	1st Jan Change
1.710 ^USD	+8.23%		+61.32%	-72.06%

08-15	Actuate Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-30	Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 2000 Dynamic Index	CI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	WUXI APPTEC CO., LTD.
	ARGENX SE
	BIONTECH SE
	INSMED INCORPORATED
	WUXI BIOLOGICS (CAYMAN) INC.
	GENMAB A/S
	PHARMAESSENTIA CORPORATION
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
	EXELIXIS, INC.
	Average
	Weighted average by Cap.